Navigation Links
Heart Imaging Technologies Wins $2.5M NIH Grant for Clinical Trials
Date:9/4/2013

DURHAM, N.C., Sept. 4, 2013 /PRNewswire/ -- HeartIT, the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, announced today that it has received a $2.5M grant from the NIH in order to develop the "Cloud Based Corelab of the Future."

Medical drugs and devices are regulated by the U.S. Food and Drug Administration (FDA) based on data from multicenter clinical trials. Over the past decade the efficiency of clinical trials has been improved by electronic data capture (EDC) systems, whose use has increased from 38% to 61% from 2006 to 2011. While medical imaging plays a key role in clinical trials, often serving as the basis for study end-points and/or safety evaluations, few if any EDC systems integrate imaging corelab workflows such as image quality assurance, site queries, and reporting of end-point analyses.

The overall goal of the NIH grant is to create a "cloud-based imaging corelab of the future" that provides support for all imaging corelab activities and integration into EDCs.

HeartIT is already a leader in the Clinical Trials market ( http://www.heartit.com/index.php/solutions ), and received an additional $2.25M NIH grant in 2011 ( http://www.heartit.com/index.php/2011/11 ).

Dr. Robert M. Judd, President of HeartIT stated: "Heart Imaging Technologies developed the world's first "zero footprint" medical image viewer, WebPAX®, which displays diagnostic-quality images in a bare bones web browser. We are the natural choice for this type of project. By moving imaging corelabs out of their traditional 'brick-and-mortar' environments and into the 'cloud,' medical images can be interpreted from anywhere in the world within minutes rather than weeks."

Judd added, "Moving corelabs to 'the cloud' will not only improve corelab workflows, but will also improve communication between the corelab and the other clinical trials stakeholders such as the CRO, the data safety and monitoring board (DSMB), the sponsor, and the FDA. In addition, making images available rapidly will enable new trial designs that reduce site-to-site variability of the study population, thereby reducing the number of patients needed to detect treatment effects, trial durations, and trial costs."

About Heart IT:

Founded in 2000 and headquartered near North Carolina's Research Triangle Park, Heart IT is a global leader in the medical image web enablement field. Their flagship product, WebPAX®, is the first FDA approved zero foot-print medical image workstation. It provides web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, WebPAX® systems currently provide secure web browser access to over one billion medical images. For more information visit our website at www.heartit.com.

This release was issued through Send2Press(R), a unit of Neotrope(R). For more information, visit Send2Press Press Release Distribution at http://www.Send2Press.com


'/>"/>
SOURCE Heart Imaging Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York
3. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
4. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
5. Heartware Schedules First Quarter Conference Call And Webcast
6. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
7. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
8. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
9. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
10. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
11. Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 This report on the opioid induced ... of the global market. Large number of chronic pain ... constipation is a major side effect of consumption of ... targeted therapy has been prescribed to treat opioid induced ... medicines, and growing awareness about the therapy are the ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... , ... “The Land of More and More”: a brilliant story for ... shares the simple and achievable answer. “The Land of More and More” is the ... Church in Angola, Indiana where he works with the children’s ministry department. , ...
(Date:1/19/2017)... ... ... Next week after January 20th, the fear for many is that the ... needs of over 30 million. Many interviews with Dr. Carol Francis at the Los ... were suppose to prioritize. Interviews provided below. , Among those present was ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... innovators, engineers, and scientists from around the world, announces the launch of its ... quick and easy portal to research breakthroughs and trending news, vital information on ...
(Date:1/19/2017)... Park City, Utah (PRWEB) , ... January 19, ... ... Sundance Film Festival in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew ... Lounge to provide a condensed version of the clinic’s leading recovery program. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... Conductor CTMS, which provides a modern CTMS workflow designed to seamlessly integrate and ... has been condensed to a single page, maximizing usability and improving efficiency significantly ...
Breaking Medicine News(10 mins):